Bcr-Abl-IN-Y9 is a novel Bcr-Abl inhibitor, potently inhibited Bcr-AblWT and Bcr-AblT315I kinases with IC50 of 0.043 μM and 0.17 μM, respectively.
MedKoo Cat#: 533251
Name: Bcr-Abl-IN-Y9
CAS#: N/A
Chemical Formula: C19H22N4O4S
Exact Mass: 402.1362
Molecular Weight: 402.47
Elemental Analysis: C, 56.70; H, 5.51; N, 13.92; O, 15.90; S, 7.97
The following data is based on the product molecular weight 402.47 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
